Tabuk Pharmaceutical Manufacturing headquarters
Tabuk Pharmaceutical Manufacturing Co., a fully owned subsidiary of Astra Industrial Group, signed an agreement with Nasdaq-listed Moderna, to commercialize the Moderna COVID-19 vaccine and future variant-specific booster candidates in Saudi Arabia, according to a press release issued by Moderna on June 11.
Tabuk Pharmaceutical Manufacturing was established in 1994, to produce, market and distribute various pharmaceutical products, according to data compiled by Argaam.
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}